C2orf66

gene
On this page

Also known as UNQ6411

Summary

C2orf66 (chromosome 2 open reading frame 66, HGNC:33809) is a protein-coding gene on chromosome 2q33.1, encoding Uncharacterized protein C2orf66 (Q6UXQ4).

Predicted to be located in extracellular region.

Source: NCBI Gene 401027 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 4 total
  • MANE Select transcript: NM_213608

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:33809
Approved symbolC2orf66
Namechromosome 2 open reading frame 66
Location2q33.1
Locus typegene with protein product
StatusApproved
AliasesUNQ6411
Ensembl geneENSG00000187944
Ensembl biotypeprotein_coding
Entrez401027

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000342506

RefSeq mRNA: 1 — MANE Select: NM_213608 NM_213608

CCDS: CCDS2317

Canonical transcript exons

ENST00000342506 — 3 exons

ExonStartEnd
ENSE00001366204196804417196805408
ENSE00001368967196807424196807622
ENSE00003902316196809214196809355

Expression profiles

Bgee: expression breadth ubiquitous, 123 present calls, max score 94.30.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0443 / max 25.0367, expressed in 11 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
330460.044311

Top tissues by expression

129 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047394.30gold quality
pituitary glandUBERON:000000776.74gold quality
adenohypophysisUBERON:000219675.57gold quality
hypothalamusUBERON:000189872.86gold quality
lower esophagus mucosaUBERON:003583464.54gold quality
left adrenal gland cortexUBERON:003582563.78gold quality
substantia nigraUBERON:000203863.32gold quality
mucosa of transverse colonUBERON:000499163.03gold quality
left adrenal glandUBERON:000123462.72gold quality
right adrenal gland cortexUBERON:003582762.67gold quality
amygdalaUBERON:000187661.93gold quality
left testisUBERON:000453361.90gold quality
temporal lobeUBERON:000187161.43gold quality
nucleus accumbensUBERON:000188261.21gold quality
right uterine tubeUBERON:000130261.17gold quality
right testisUBERON:000453461.16gold quality
Ammon’s hornUBERON:000195461.05gold quality
testisUBERON:000047360.60gold quality
right adrenal glandUBERON:000123360.52gold quality
anterior cingulate cortexUBERON:000983559.49gold quality
stromal cell of endometriumCL:000225559.10gold quality
right atrium auricular regionUBERON:000663158.94gold quality
adrenal glandUBERON:000236958.81gold quality
islet of LangerhansUBERON:000000658.67gold quality
omental fat padUBERON:001041457.36gold quality
brainUBERON:000095557.32gold quality
skin of legUBERON:000151156.98gold quality
skin of abdomenUBERON:000141656.97gold quality
caudate nucleusUBERON:000187356.88gold quality
zone of skinUBERON:000001456.82gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.27

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

60 targeting C2orf66, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-806899.9873.852376
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-338-5P99.9272.342951
HSA-MIR-4671-3P99.8872.461045
HSA-MIR-30A-3P99.8769.742928
HSA-MIR-30D-3P99.8769.922917
HSA-MIR-30E-3P99.8769.682942
HSA-MIR-449299.8768.253611
HSA-MIR-548AR-3P99.8571.263889
HSA-MIR-548AZ-5P99.8369.943230
HSA-MIR-548T-5P99.8369.913220
HSA-MIR-449599.8272.083080
HSA-MIR-548AZ-3P99.8270.563549
HSA-MIR-548BC99.8270.613524
HSA-MIR-548E-3P99.8270.593514
HSA-MIR-548F-3P99.8270.593540
HSA-MIR-4760-5P99.8069.881619
HSA-MIR-807699.7868.521170
HSA-MIR-548A-3P99.7670.583524
HSA-MIR-64699.6867.841645
HSA-MIR-29B-2-5P99.6768.981726
HSA-MIR-7-5P99.6770.531809

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriopgap1ENSDARG00000062465
mus_musculusGm34066ENSMUSG00000109809
rattus_norvegicusC9h2orf66ENSRNOG00000067303
drosophila_melanogasterPGAP1FBGN0029789
caenorhabditis_elegansWBGENE00011835

Paralogs (1): PGAP1 (ENSG00000197121)

Protein

Protein identifiers

Uncharacterized protein C2orf66Q6UXQ4 (reviewed: Q6UXQ4)

All UniProt accessions (1): A0A5K1VW65

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Secreted.

RefSeq proteins (1): NP_998773* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR031699DUF4720Family

Pfam: PF15846

UniProt features (2 total): signal peptide 1, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6UXQ4-F172.230.09

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 17 (showing top): FREAC3_01, RFX1_02, MIR4666A_3P, MIR338_5P, MIR3978, MIR29B_2_5P, MIR4760_5P, MIR4735_5P, MIR8061, MIR5583_3P, MIR20B_3P, BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP, BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP, OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP, SMAD3_Q6

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (1): extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure1

Protein interactions and networks

STRING

282 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C2orf66CCDC190Q86UF4515
C2orf66TMEM217BA0A494BZU4480
C2orf66TMEM217Q8N7C4479
C2orf66Q8NG57Q8NG57447
C2orf66C2CD4BA6NLJ0366
C2orf66RPF2Q9H7B2360
C2orf66SLC41A2Q96JW4350
C2orf66PIGTQ969N2348
C2orf66PGAP3Q96FM1348
C2orf66PIGKQ92643348
C2orf66GPAA1O43292347
C2orf66CSNK1G1Q9HCP0338
C2orf66PIGSQ96S52320
C2orf66MPZL2O60487307
C2orf66PLA2G4CQ9UP65305

IntAct

2 interactions, top by confidence:

ABTypeScore
C2orf66EFCAB2psi-mi:“MI:0915”(physical association)0.400

BioGRID (2): C2orf66 (Positive Genetic), EFCAB2 (Affinity Capture-MS)

ESM2 similar proteins: A0A1B0GTC6, A0A2U3Y4D7, A0A2Y9HRM2, G5BQH4, G5BWH8, G8F204, P01257, P01261, P02652, P02656, P06759, P0CE37, P0CE39, P0CF78, P0DJD2, P0DJG2, P0DKV2, P0DKV3, P0DKV4, P0DM95, P0DM96, P0DMP9, P0DMR2, P0DMT9, P0DN36, P0DP50, P0DP84, P0DP85, P0DP86, P0DP87, P0DTQ3, P0DTQ5, P0DTR6, P0DTS5, P18656, P18659, P33622, P40148, P41547, P70160

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

4 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

194 predictions. Top by Δscore:

VariantEffectΔscore
2:196807623:C:CCacceptor_gain1.0000
2:196809208:TCTTA:Tdonor_loss1.0000
2:196809209:CTTA:Cdonor_loss1.0000
2:196809210:TTAC:Tdonor_loss1.0000
2:196809211:TA:Tdonor_loss1.0000
2:196809212:ACC:Adonor_loss1.0000
2:196809213:C:CAdonor_loss1.0000
2:196807019:TTCA:Tdonor_gain0.9900
2:196807621:AA:Aacceptor_gain0.9900
2:196809212:A:ACdonor_gain0.9900
2:196809213:C:CCdonor_gain0.9900
2:196805409:CTGA:Cacceptor_loss0.9800
2:196805410:T:Gacceptor_loss0.9800
2:196807418:TTTTA:Tdonor_loss0.9800
2:196807419:TTTA:Tdonor_loss0.9800
2:196807420:TTAC:Tdonor_loss0.9800
2:196807421:TAC:Tdonor_loss0.9800
2:196807422:A:Tdonor_loss0.9800
2:196807423:CCTG:Cdonor_loss0.9800
2:196807620:AAA:Aacceptor_gain0.9800
2:196807622:ACTA:Aacceptor_loss0.9700
2:196807624:T:Cacceptor_loss0.9700
2:196809213:CCAG:Cdonor_gain0.9700
2:196805406:CAC:Cacceptor_gain0.9600
2:196807622:ACT:Aacceptor_gain0.9600
2:196807623:CTA:Cacceptor_gain0.9600
2:196807624:T:Aacceptor_gain0.9600
2:196807618:AAAAA:Aacceptor_gain0.9500
2:196807620:AAACT:Aacceptor_gain0.9500
2:196807621:AACTA:Aacceptor_gain0.9500

AlphaMissense

646 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:196809247:C:AW47C0.883
2:196809247:C:GW47C0.883
2:196809249:A:GW47R0.878
2:196809249:A:TW47R0.878
2:196807617:G:CF60L0.874
2:196807617:G:TF60L0.874
2:196807619:A:GF60L0.874
2:196807620:A:CF59L0.832
2:196807620:A:TF59L0.832
2:196807622:A:GF59L0.832
2:196809223:G:CN55K0.737
2:196809223:G:TN55K0.737
2:196809244:C:AK48N0.732
2:196809244:C:GK48N0.732
2:196807609:A:TL63H0.712
2:196809220:T:AR56S0.710
2:196809220:T:GR56S0.710
2:196809239:A:TL50H0.704
2:196807597:A:GF67S0.693
2:196807618:A:CF60C0.685
2:196809248:C:AW47L0.679
2:196807609:A:GL63P0.677
2:196807587:T:AR70S0.673
2:196807587:T:GR70S0.673
2:196807566:A:CF77L0.666
2:196807566:A:TF77L0.666
2:196807568:A:GF77L0.666
2:196807604:C:GA65P0.664
2:196807621:A:GF59S0.661
2:196807618:A:GF60S0.657

dbSNP variants (sampled 300 via entrez): RS1000089402 (2:196829813 T>C), RS1000090416 (2:196806575 G>T), RS1000141937 (2:196823365 G>A), RS1000142798 (2:196806329 C>G), RS1000173692 (2:196832004 G>A), RS1000191013 (2:196810463 T>C), RS1000335206 (2:196824236 T>C), RS1000356019 (2:196826834 C>G,T), RS1000368279 (2:196819869 G>C,T), RS1000475518 (2:196806614 G>T), RS1000763016 (2:196806963 G>A), RS1000778598 (2:196819424 T>A), RS1000881019 (2:196825860 G>T), RS1001091435 (2:196825432 T>C), RS1001209384 (2:196829702 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST010396_207Gut microbiota (bacterial taxa, hurdle binary method)4.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0007874gut microbiome measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

10 total (human), top 10 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
1-hydroxypyrenedecreases expression1
3,4,5,4’-tetramethoxystilbeneaffects expression1
(+)-JQ1 compoundincreases expression1
Resveratrolaffects cotreatment, decreases expression1
Air Pollutants, Occupationaldecreases expression1
Benzo(a)pyreneaffects methylation, decreases methylation1
Cisplatinincreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Acrylamideincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.